パーキンソン病の患者における脳の機能ネットワークの異常
Wei Wei1, Xinhui Wang1, Chao Han2
1Department of Radiology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, China.
Frontiers in neuroscience
|August 27, 2025
まとめ
パーキンソン病 (PD) の脳機能ネットワークは病期によって変化します. これらのネットワークの変化は臨床的重症と相関し,PDの進行に関する洞察を提供します.
科学分野:
- 神経科学
- 医療用イメージング
- ネットワーク科学
背景:
- パーキンソン病 (PD) は,進行的な障害と不明な病原性を持つ神経変性疾患である.
- PDのニューラルネットワークの変化を理解することは 診断と治療に不可欠です
研究 の 目的:
- パーキンソン病の異なる段階における脳の機能ネットワークトポロジの変化を,静止状態の機能磁気共鳴画像 (rs-fMRI) とグラフ解析を用いて調査する.
- 初期段階のPD (PD-E),中期から後半段階のPD (PD-M),および健康な対照群の脳の機能ネットワークのトポロジカル特性を比較する.
主な方法:
- 58人のPD患者 (29人のPD-E,29人のPD-M) と29人のHC参加者を募集した.
- rs-fMRIとグラフ解析を使用して,グローバル,地域,モジュール型の脳ネットワークトポロジーを評価しました.
- MDS-UPDRS IIIとH&Yステージを含む臨床評価と相関するトポロジカル特徴.
主要な成果:
- PD患者 (PD-EとPD-Mの両方) は,HCと比較してクラスタリング係数が低い全局ネットワークトポロジーを示しました.
- 地域分析では,PD患者の側頭側頭部の中心部が低下し,デフォルトモードと前頭側頭部ネットワークの中心部が増加したことが明らかになった.
- 左中側前頭回および右中側側側頭回における特定の結節中心性指標は,PDの臨床的重症度 (MDS- UPDRS IIIおよびH&Yステージ) と関連していました.
結論:
- パーキンソン病では脳の機能ネットワークが 障害となり 疾患の段階によって 障害の度合いは異なります
- これらの発見は,PDの重症度に関連するニューラルネットワークのトポロジカル変化の理解を高めています.
- この研究は,PDの進行とその臨床的表れを特徴づけるためのネットワーク分析の可能性を強調しています.
さらに関連する動画
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.8K
関連する概念動画
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Brainstem
3.0K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.0K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
